Long-acting cabotegravir plus rilpivirine as maintenance therapy: ATLAS week-48 results

被引：0
|
作者：
Margolis, D. A. [1 ]
Swindells, S. [2 ]
Andrade-Villanueva, J-F [3 ]
Richmond, G. J. [4 ]
Rizzardini, G. [5 ]
Baumgarten, A. [6 ]
Masia, M. D. M. [7 ]
Latiff, G. [8 ]
Pokrovsky, V. [9 ]
Mrus, J. M. [1 ]
Huang, J. O. [10 ]
Hudson, K. J. [1 ]
Smith, K. Y. [1 ]
Williams, P. [11 ]
Spreen, W. R. [1 ]
机构：
[1] ViiV Healthcare, Res Triangle Pk, NC USA
[2] Univ Nebraska Med Ctr, Omaha, NE USA
[3] Univ Guadalajara, Guadalajara, Jalisco, Mexico
[4] Broward Hlth Imperial Point, Broward Hlth Med Ctr, Ft Lauderdale, FL USA
[5] Fatebenefratelli Sacco Hosp, Milan, Italy
[6] MIB Infect Dis Med Ctr, Berlin, Germany
[7] Hosp Gen Univ Elche, Alicante, Spain
[8] Maxwell Ctr, Durban, South Africa
[9] Russian Fed Guidance Ctr AIDS, Moscow, Russia
[10] GlaxoSmithKline, Mississauga, ON, Canada
[11] Janssen Res & Dev, Beerse, Belgium
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P12
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] Cabotegravir plus rilpivirine as long-acting maintenance therapy: LATTE-2 week 48 results
    Margolis, D.
    Podzamczer, D.
    Stellbrink, H-J
    Lutz, T.
    Angel, J.
    Richmond, G.
    Clotet, B.
    Gutierrez, F.
    Sloan, L.
    Griffith, S.
    St Clair, M.
    Dorey, D.
    Ford, S.
    Mrus, J.
    Crauwels, H.
    Smith, K.
    Williams, P.
    Spreen, W.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [2] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS Week 96 results
    Swindells, S.
    Lutz, T.
    Van Zyl, L.
    Porteiro, N.
    Benn, P.
    Huang, J.
    Harrington, C.
    Hove, K.
    Ford, S.
    Talarico, C.
    Chounta, V.
    Crauwels, H.
    Van Solingen-Ristea, R.
    Vanveggel, S.
    Margolis, D.
    Smith, K.
    Vandermeulen, K.
    Spreen, W.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 19 - 21
  • [3] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS week 96 results
    Swindells, Susan
    Lutz, Thomas
    Van Zyl, Lelanie
    Porteiro, Norma
    Benn, Paul
    Huang, Jenny O.
    Harrington, Conn M.
    Hove, Kai
    Ford, Susan L.
    Talarico, Christine L.
    Chounta, Vasiliki
    Crauwels, Herta
    Van Solingen-Ristea, Rodica
    Vanveggel, Simon
    Margolis, David A.
    Smith, Kimberly Y.
    Vandermeulen, Kati
    Spreen, William R.
    Baum, Alexander
    [J]. INFECTION, 2021, 49 (SUPPL 1) : S7 - S8
  • [4] Long-active cabotegravir plus rilpivirine for HIV maintenance: FLAIR week-48 results
    Orkin, C.
    Arasteh, K.
    Hernandez-Mora, M. G.
    Pokrovsky, V.
    Overton, E. T.
    Girard, P-M
    Oka, S.
    D'Amico, R.
    Dorey, D.
    Griffith, S.
    Margolis, D. A.
    Williams, P.
    Parys, W.
    Spreen, W. R.
    [J]. HIV MEDICINE, 2019, 20 : 6 - 7
  • [5] Patient views on long acting HIV treatment: Cabotegravir plus rilpivirine as maintenance therapy (ATLAS 48 week results)
    Murray, M.
    Antela, A.
    Mills, A.
    Chounta, V.
    Huang, J.
    Jaeger, H.
    Khuong-Josses, M-A.
    Hudson, K.
    Spreen, W.
    Williams, P.
    Margolis, D. M.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 2 - 2
  • [6] Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
    Rizzardini, Giuliano
    Overton, Edgar T.
    Orkin, Chloe
    Swindells, Susan
    Arasteh, Keikawus
    Gorgolas Hernandez-Mora, Miguel
    Pokrovsky, Vadim
    Girard, Pierre-Marie
    Oka, Shinichi
    Andrade-Villanueva, Jaime F.
    Richmond, Gary J.
    Baumgarten, Axel
    Masia, Mar
    Latiff, Gulam
    Griffith, Sandy
    Harrington, Conn M.
    Hudson, Krischan J.
    St Clair, Marty
    Talarico, Christine L.
    Patel, Parul
    Cutrell, Amy
    Van Eygen, Veerle
    D'Amico, Ronald
    Mrus, Joseph M.
    Wu, Sterling
    Ford, Susan L.
    Chow, Ken
    Roberts, Jeremy
    Wills, Angela
    Walters, Nicola
    Vanveggel, Simon
    Van Solingen-Ristea, Rodica
    Crauwels, Herta
    Smith, Kimberly Y.
    Spreen, William R.
    Margolis, David A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 85 (04) : 498 - 506
  • [7] Long-acting cabotegravir plus rilpivirine for HIV treatment: FLAIR week 96 results
    Orkin, C.
    Oka, S.
    Philibert, P.
    Brinson, C.
    Bassa, A. C.
    Gusev, D.
    Degen, O.
    Gonzalez Garcia, J.
    D'Amico, R.
    Dorey, D.
    Griffith, S.
    Margolis, D. A.
    St Clair, M.
    Williams, P.
    Spreen, W. R.
    [J]. HIV MEDICINE, 2020, 21 : 14 - 14
  • [8] The future of long-acting cabotegravir plus rilpivirine therapy: deeds and misconceptions
    Rusconi, Stefano
    Santoro, Maria M.
    Capetti, Amedeo F.
    Gianotti, Nicola
    Zazzi, Maurizio
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [9] Outcomes for women receiving long-acting cabotegravir plus rilpivirine monthly and every two months: ATLAS-2M study Week 48 results
    Benn, P.
    Quercia, R.
    Hudson, K.
    Wang, Y.
    Chounta, V.
    Talarico, C.
    Ford, S.
    Cutrell, A.
    Margolis, D.
    Van Solingen-Ristea, R.
    Vanveggel, S.
    Van Eygen, V.
    Polli, J.
    de Ruiter, A.
    Smith, K.
    Spreen, W.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 28 - 29
  • [10] Safety and efficacy of cabotegravir plus rilpivirine long-acting with and without oral lead-in: FLAIR Week 124 results
    D'Amico, R.
    Orkin, C.
    Bernal Morell, E.
    Tan, D.
    Katner, H.
    Singh, Y.
    Stellbrink, H.
    Belonosova, E.
    DeMoor, R.
    Griffith, S.
    Thiagarajah, S.
    Van Solingen-Ristea, R.
    Crauwels, H.
    Ford, S.
    Patel, P.
    Cutrell, A.
    Smith, K.
    Vandermeulen, K.
    Margolis, D.
    St Clair, M.
    Spreen, W.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 10 - 12
12345